Taiwanese Pharmaceuticals & Biotech Undervalued over 20% based on DCF

Bora Pharmaceuticals

Market Cap: NT$57.9b

Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.

ScinoPharm Taiwan

Market Cap: NT$15.4b

A pharmaceutical company, provides active pharmaceutical ingredient (API) development and manufacturing and injectable solutions in Taiwan, rest of Asia, Europe, and the Americas.

YungShin Global Holding

Market Cap: NT$14.8b

Through its subsidiaries, engages in investing, manufacturing, and sale of medicines, veterinary drugs, agricultural chemicals, industrial medicines, and cosmetics.

Standard Chemical & Pharmaceutical

Market Cap: NT$11.2b

Manufactures and sells pharmaceutical products in Taiwan and internationally.

Sinphar PharmaceuticalLtd

Market Cap: NT$6.2b

Engages in the production, processing, selling, and trading of various medicines, chinese medicines, medical cosmetic products and nutrients in Taiwan, Mainland China, Vietnam, Indonesia, and internationally.

Orient Pharma

Market Cap: NT$5.4b

Engages in the development of new drugs in Taiwan and internationally.

Nang Kuang Pharmaceutical

Market Cap: NT$3.2b

Manufactures, processes, trades in, imports, and exports pharmaceuticals and medical devices in Taiwan, China, Japan, the United States, and internationally.

Syngen BiotechLtd

Market Cap: NT$2.3b

Engages in the research, development, manufacturing, and sale of microbial pharmaceutical raw materials, biological pesticides, fertilizers and biochemical nutritional products, and preventive medicines in Taiwan and internationally.

Synbio Tech

Market Cap: NT$1.6b

Manufactures and sells human healthcare products and probiotics for animals.

Winston Medical Supply

Market Cap: NT$868.4m

Develops, manufactures, and distributes pharmaceuticals, nutrition supplements, and cosmeceutical products in Taiwan and internationally.